BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34922945)

  • 21. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice.
    Johnson BL; d'Alincourt Salazar M; Mackenzie-Dyck S; D'Apuzzo M; Shih HP; Manuel ER; Diamond DJ
    PLoS One; 2019; 14(9):e0221810. PubMed ID: 31490946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia.
    Greer RL; Staley BK; Liou A; Hebrok M
    Gastroenterology; 2013 Nov; 145(5):1088-1097.e8. PubMed ID: 23891977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
    Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
    Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
    Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
    Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.
    Zhang Z; Li H; Deng Y; Schuck K; Raulefs S; Maeritz N; Yu Y; Hechler T; Pahl A; Fernández-Sáiz V; Wan Y; Wang G; Engleitner T; Öllinger R; Rad R; Reichert M; Diakopoulos KN; Weber V; Li J; Shen S; Zou X; Kleeff J; Mihaljevic A; Michalski CW; Algül H; Friess H; Kong B
    Gastroenterology; 2021 Nov; 161(5):1601-1614.e23. PubMed ID: 34303658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation.
    Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.
    Wong CH; Li YJ; Chen YC
    World J Gastroenterol; 2016 Aug; 22(31):7046-57. PubMed ID: 27610015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions.
    Lubeseder-Martellato C; Alexandrow K; Hidalgo-Sastre A; Heid I; Boos SL; Briel T; Schmid RM; Siveke JT
    EBioMedicine; 2017 Feb; 15():90-99. PubMed ID: 28057438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
    Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
    Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study.
    Huang L; Yang H; Chen K; Yuan J; Li J; Dai G; Gu M; Shi Y
    Clin Transl Med; 2023 Dec; 13(12):e1500. PubMed ID: 38037549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.
    Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
    Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
    Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
    Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN loss accelerates KrasG12D-induced pancreatic cancer development.
    Hill R; Calvopina JH; Kim C; Wang Y; Dawson DW; Donahue TR; Dry S; Wu H
    Cancer Res; 2010 Sep; 70(18):7114-24. PubMed ID: 20807812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis.
    Beel S; Kolloch L; Apken LH; Jürgens L; Bolle A; Sudhof N; Ghosh S; Wardelmann E; Meisterernst M; Steinestel K; Oeckinghaus A
    Nat Commun; 2020 Jul; 11(1):3409. PubMed ID: 32641778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer.
    Nimmakayala RK; Ogunleye AO; Parte S; Krishna Kumar N; Raut P; Varadharaj V; Perumal NK; Nallasamy P; Rauth S; Cox JL; Lele SM; Batra SK; Ponnusamy MP
    Cell Death Dis; 2022 Oct; 13(10):839. PubMed ID: 36180487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia.
    Ebine K; Chow CR; DeCant BT; Hattaway HZ; Grippo PJ; Kumar K; Munshi HG
    Sci Rep; 2016 Jul; 6():29133. PubMed ID: 27364947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.